Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator
NCT06643052 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 6300
Last updated 2026-04-07
Summary
Early neonatal sepsis requires rapid and efficient intervention to prevent morbidity and mortality. Management of such a case includes invasive blood examinations, elongation of maternal and neonatal length of stay, and empiric antibiotic therapy. These actions has major side effects. On 2017, Kaiser-Permanente started using a calculator that weighs the chances for early onset neonatal sepsis, and states the best investigation and follow-up regimn for the specific newborn infant. Eversince, policy of managing neonatal suspected early onset sepsis has chaged globally, including in Israel. Current knowledge regarding the local outcome since the use of the calculatir is scarce.
The goal of the study is to evaluate the change in management of suspected neonatal early onset sepsis, including its economic value, between periods before and after assimilation of the calculator in Hillel Yaffe nedica l center.
Conditions
- Neonatal Early-onset Sepsis
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Principal Investigators
-
Erez Nadir, MD · Hillel Yaffe Medical Center
Eligibility
- Max Age
- 7 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-12-01
- Primary Completion
- 2027-06-01
- Completion
- 2027-12-01
Countries
- Israel
Study Locations
More Related Trials
-
Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis
NCT00926497 ·Status: COMPLETED ·Phase: NA
-
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease
NCT03923543 ·Status: COMPLETED
-
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
NCT03280147 ·Status: COMPLETED ·Phase: PHASE3
-
Early-Onset Sepsis an NICHD/CDC Surveillance Study
NCT02410486 ·Status: COMPLETED
-
Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis
NCT06633770 ·Status: NOT_YET_RECRUITING
-
White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis
NCT03880305 ·Status: UNKNOWN
-
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
NCT05692128 ·Status: UNKNOWN
-
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
NCT06206590 ·Status: RECRUITING
-
Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis
NCT01362504 ·Status: COMPLETED
-
Prognostic Value of Complete Blood Count in Severe Infections
NCT03685071 ·Status: UNKNOWN
-
Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya
NCT02346331 ·Status: COMPLETED ·Phase: NA
-
Neonatal Procalcitonin Intervention Study
NCT00854932 ·Status: UNKNOWN ·Phase: NA
-
CO2 Gap Changes Versus Inferior Vena Cava Collapsibility in Relation to Cardiac Index as a Prognostic Value in Septic Shock
NCT06119815 ·Status: RECRUITING ·Phase: NA
-
Thromboelastography in in Patients With Sepsis
NCT00994877 ·Status: UNKNOWN
-
Simplified Antibiotic Therapy for Sepsis in Young Infants
NCT01027429 ·Status: COMPLETED ·Phase: PHASE3
-
Influencing Factors of Vancomycin Trough Level in Critically Ill Children With Sepsis
NCT06661772 ·Status: COMPLETED
-
Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
NCT06640504 ·Status: COMPLETED
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis
NCT07245966 ·Status: COMPLETED
-
Prevailing Microorganisms Causing Neonatal Sepsis in Neonatal Intensive Care Unit (Prospective Study)Prevailing Microorganisms Causing Neonatal Sepsis in Neonatal Intensive Care Unit (Prospective Study)
NCT03308526 ·Status: UNKNOWN
-
Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates
NCT03299751 ·Status: COMPLETED ·Phase: NA
-
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
NCT06256198 ·Status: NOT_YET_RECRUITING
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS
NCT05796115 ·Status: UNKNOWN ·Phase: NA
-
Unfractioned Heparin for Treatment of Sepsis
NCT00100308 ·Status: COMPLETED ·Phase: PHASE3